Literature DB >> 29648584

The American College of Cardiology 2018; a Starbuckian ODYSSEY and a Black Barbershop.

Matthew J Daniels1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29648584      PMCID: PMC5909639          DOI: 10.1093/cvr/cvy072

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  14 in total

1.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Marco Valgimigli; Héctor Bueno; Robert A Byrne; Jean-Philippe Collet; Francesco Costa; Anders Jeppsson; Peter Jüni; Adnan Kastrati; Philippe Kolh; Laura Mauri; Gilles Montalescot; Franz-Josef Neumann; Mate Petricevic; Marco Roffi; Philippe Gabriel Steg; Stephan Windecker; Jose Luis Zamorano; Glenn N Levine
Journal:  Eur Heart J       Date:  2018-01-14       Impact factor: 29.983

2.  PCSK9 inhibition and clinical cardiovascular outcomes in patients with atherosclerotic cardiovascular disease.

Authors:  Ulf Landmesser
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

3.  Novel concepts for the role of smooth muscle cells in vascular disease: towards a new smooth muscle cell classification.

Authors:  Marie-Luce Bochaton-Piallat; Magnus Bäck
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

4.  A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops.

Authors:  Ronald G Victor; Kathleen Lynch; Ning Li; Ciantel Blyler; Eric Muhammad; Joel Handler; Jeffrey Brettler; Mohamad Rashid; Brent Hsu; Davontae Foxx-Drew; Norma Moy; Anthony E Reid; Robert M Elashoff
Journal:  N Engl J Med       Date:  2018-03-12       Impact factor: 91.245

5.  Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote.

Authors:  Zhenze Zhao; Yetsa Tuakli-Wosornu; Thomas A Lagace; Lisa Kinch; Nicholas V Grishin; Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  Am J Hum Genet       Date:  2006-07-18       Impact factor: 11.025

6.  Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO Trial.

Authors:  Francesca Maria Notarangelo; Giuseppe Maglietta; Paola Bevilacqua; Marco Cereda; Piera Angelica Merlini; Giovanni Quinto Villani; Paolo Moruzzi; Giampiero Patrizi; Guidantonio Malagoli Tagliazucchi; Antonio Crocamo; Angela Guidorossi; Filippo Pigazzani; Elisa Nicosia; Giorgia Paoli; Marco Bianchessi; Mario Angelo Comelli; Caterina Caminiti; Diego Ardissino
Journal:  J Am Coll Cardiol       Date:  2018-03-11       Impact factor: 24.094

7.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Authors:  Christopher P Cannon; Eugene Braunwald; Carolyn H McCabe; Daniel J Rader; Jean L Rouleau; Rene Belder; Steven V Joyal; Karen A Hill; Marc A Pfeffer; Allan M Skene
Journal:  N Engl J Med       Date:  2004-03-08       Impact factor: 91.245

8.  Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.

Authors:  Rasha Al-Lamee; David Thompson; Hakim-Moulay Dehbi; Sayan Sen; Kare Tang; John Davies; Thomas Keeble; Michael Mielewczik; Raffi Kaprielian; Iqbal S Malik; Sukhjinder S Nijjer; Ricardo Petraco; Christopher Cook; Yousif Ahmad; James Howard; Christopher Baker; Andrew Sharp; Robert Gerber; Suneel Talwar; Ravi Assomull; Jamil Mayet; Roland Wensel; David Collier; Matthew Shun-Shin; Simon A Thom; Justin E Davies; Darrel P Francis
Journal:  Lancet       Date:  2017-11-02       Impact factor: 79.321

Review 9.  Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

Authors:  Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Fernando Alfonso; Carlos Macaya; Theodore A Bass; Marco A Costa
Journal:  J Am Coll Cardiol       Date:  2007-03-26       Impact factor: 24.094

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.